MedTrace Logo

Cognitive Therapy Software for Improving Cognitive Function for Patients With Mild Cognitive Impairment

NCT06264557 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-10-02

No results posted yet for this study

Summary

Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment

Conditions

Interventions

DEVICE

SB-100

Cognitive training will be conducted once a day, and it will take 15 to 30 minutes. It consists of cognitive training and educational videos.

OTHER

Educational book

Book of education on daily rules for preventing dementia

Sponsors & Collaborators

  • Rowan

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-03-13
Completion
2025-06-02

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06264557 on ClinicalTrials.gov